SpringWorks Therapeutics
Stamford
About SpringWorks Therapeutics
SpringWorks Therapeutics focuses on developing and commercializing innovative therapies for cancer treatment. The company specializes in targeted oncology, aiming to provide solutions that address unmet medical needs in the oncology space. SpringWorks offers a range of therapies, including those that target specific genetic mutations in tumors. Their research emphasizes precision medicine, utilizing advanced methodologies to enhance treatment efficacy. The company engages in collaborations to accelerate the development of its pipeline and improve patient outcomes in oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $1.0B
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2023)
- Ticker: nasdaq:SWTX
- Website: springworkstx.com
- Phone: 203-883-9490
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/springworks-therapeutics-114085 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.